{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:29:55Z","timestamp":1781587795852,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["23K15944"],"award-info":[{"award-number":["23K15944"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["22K09843"],"award-info":[{"award-number":["22K09843"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The ROCK inhibitor ripasudil hydrochloride hydrate was shown to have axonal protective effects in TNF-induced optic nerve degeneration. The \u03b12-adrenoreceptor agonist brimonidine was also shown to exert axonal protection. The current study aimed to elucidate whether additive axonal protection was achieved by the simultaneous injection of ripasudil and brimonidine and examine the association with AMPK activation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Intravitreal administration was performed in the following groups: PBS, TNF, or TNF with ripasudil, with brimonidine, or with a combination of ripasudil and brimonidine. Axon numbers were counted to evaluate the effects against axon loss. Immunoblot analysis was performed to examine phosphorylated AMPK expression in optic nerves, and immunohistochemical analysis was performed to evaluate the expression levels of p-AMPK and neurofilament in the optic nerve.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Both ripasudil alone or brimonidine alone resulted in significant neuroprotection against TNF-induced axon loss. The combination of ripasudil and brimonidine showed additive protective effects. Combined ripasudil and brimonidine plus TNF significantly upregulated p-AMPK levels in the optic nerve compared with the TNF groups. Immunohistochemical analysis revealed that p-AMPK is present in axons and enhanced by combination therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The combination of ripasudil and brimonidine may have additive protective effects compared with single-agent treatment alone. These protective effects may be at least partially associated with AMPK activation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10792-024-03095-9","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T06:01:51Z","timestamp":1712728911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Axonal protection by combination of ripasudil and brimonidine with upregulation of p-AMPK in TNF-induced optic nerve degeneration"],"prefix":"10.1007","volume":"44","author":[{"given":"Mizuki","family":"Otsubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Sase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibuki","family":"Arizono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kitaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"3095_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.05.002","volume":"37","author":"T Inoue","year":"2013","unstructured":"Inoue T, Tanihara H (2013) Rho-associated kinase inhibitors: a novel glaucoma therapy. Prog Retin Eye Res 37:1\u201312. https:\/\/doi.org\/10.1016\/j.preteyeres.2013.05.002","journal-title":"Prog Retin Eye Res"},{"key":"3095_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ajo.2021.01.019","volume":"226","author":"AJ Sit","year":"2021","unstructured":"Sit AJ, Gupta D, Kazemi A, McKee H, Challa P, Liu KC, Lopez J, Kopczynski C, Heah T (2021) Netarsudil improves trabecular outflow facility in patients with primary open angle glaucoma or ocular hypertension: a phase 2 study. Am J Ophthalmol 226:262\u2013269. https:\/\/doi.org\/10.1016\/j.ajo.2021.01.019","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"3095_CR3","doi-asserted-by":"publisher","first-page":"19640","DOI":"10.1038\/srep19640","volume":"19","author":"Y Kaneko","year":"2016","unstructured":"Kaneko Y, Ohta M, Inoue T, Mizuno K, Isobe T, Tanabe S, Tanihara H (2016) Effects of K-115 (ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm\u2019s canal endothelial cells. Sci Rep 19(6):19640. https:\/\/doi.org\/10.1038\/srep19640","journal-title":"Sci Rep"},{"key":"3095_CR4","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.1016\/S0039-6257(01)00205-3","volume":"45","author":"M Vidal-Sanz","year":"2001","unstructured":"Vidal-Sanz M, Lafuente MP, Mayor S, Imperial JMD, Villegas-P\u00e9rez MP (2001) Retinal ganglion cell death induced by retinal ischemia. Neuroprotective effects of two alpha-2 agonists. Surv Ophthalmol 45:S261\u2013S267","journal-title":"Surv Ophthalmol"},{"key":"3095_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/S0952523807070150","volume":"24","author":"HS Kim","year":"2007","unstructured":"Kim HS, Chang YI, Kim JH, Park CK (2007) Alteration of retinal intrinsic survival signal and effect of alpha2-adrenergic receptor agonist in the retina of the chronic ocular hypertension rat. Vis Neurosci 24:127\u2013139. https:\/\/doi.org\/10.1017\/S0952523807070150","journal-title":"Vis Neurosci"},{"key":"3095_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.exer.2006.10.002","volume":"84","author":"NO Danylkova","year":"2007","unstructured":"Danylkova NO, Alcala SR, Pomeranz HD, McLoon LK (2007) Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy. Exp Eye Res 84:293\u2013301. https:\/\/doi.org\/10.1016\/j.exer.2006.10.002","journal-title":"Exp Eye Res"},{"key":"3095_CR7","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1167\/iovs.17-22000","volume":"58","author":"Y Kitaoka","year":"2017","unstructured":"Kitaoka Y, Sase K, Tsukahara C, Kojima K, Shiono A, Kogo J, Tokuda N, Takagi H (2017) Axonal protection by ripasudil, a Rho kinase inhibitor, via modulating autophagy in TNF-induced optic nerve degeneration. Invest Ophthalmol Vis Sci 58:5056\u20135064. https:\/\/doi.org\/10.1167\/iovs.17-22000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3095_CR8","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00417-015-3005-3","volume":"253","author":"Y Kitaoka","year":"2015","unstructured":"Kitaoka Y, Kojima K, Munemasa Y, Sase K, Takagi H (2015) Axonal protection by brimonidine with modulation of p62 expression in TNF-induced optic nerve degeneration. Graefes Arch Clin Exp Ophthalmol 253:1291\u20131296. https:\/\/doi.org\/10.1007\/s00417-015-3005-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3095_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3390\/life13071455","volume":"13","author":"A Dammak","year":"2023","unstructured":"Dammak A, Naves JS, Huete-Toral F, Carracedo G (2023) New biomarker combination related to oxidative stress and inflammation in primary open-angle glaucoma. Life (Basel) 13:1455. https:\/\/doi.org\/10.3390\/life13071455","journal-title":"Life (Basel)"},{"key":"3095_CR10","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.3390\/jcm11175232","volume":"11","author":"Y Jung","year":"2022","unstructured":"Jung Y, Ohn K, Shin H, Oh SE, Park CK, Park HYL (2022) Factors associated with elevated tumor necrosis factor-\u03b1 in aqueous humor of patients with open-angle glaucoma. J Clin Med 11:5232. https:\/\/doi.org\/10.3390\/jcm11175232","journal-title":"J Clin Med"},{"key":"3095_CR11","first-page":"1787","volume":"42","author":"G Tezel","year":"2001","unstructured":"Tezel G, Li LY, Patil RV, Wax MB (2001) TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 42:1787\u20131794","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3095_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0079-6123(08)01128-X","volume":"173","author":"G Tezel","year":"2008","unstructured":"Tezel G (2008) TNF-\u03b1 signaling in glaucomatous neurodegeneration. Prog Brain Res 173:409\u2013421. https:\/\/doi.org\/10.1016\/S0079-6123(08)01128-X","journal-title":"Prog Brain Res"},{"key":"3095_CR13","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1167\/iovs.05-0299","volume":"47","author":"Y Kitaoka","year":"2007","unstructured":"Kitaoka Y, Kitaoka Y, Kwong JMK, Ross-Cisneros FN, Wang J, Tsai RK, Sadun AA, Lam TT (2007) TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. Invest Ophthalmol Vis Sci 47:1448\u20131457. https:\/\/doi.org\/10.1167\/iovs.05-0299","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3095_CR14","doi-asserted-by":"publisher","first-page":"705405","DOI":"10.3389\/fphar.2021.705405","volume":"12","author":"F Conti","year":"2021","unstructured":"Conti F, Romano GL, Eandi CM, Toro MD, Rejdak R, Di Benedetto G, Lazzara F, Bernardini R, Drago F, Cantarella G, Bucolo C (2021) Brimonidine is neuroprotective in animal paradigm of retinal ganglion cell damage. Front Pharmacol 12:705405. https:\/\/doi.org\/10.3389\/fphar.2021.705405","journal-title":"Front Pharmacol"},{"key":"3095_CR15","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s10792-023-02706-1","volume":"43","author":"K Sase","year":"2023","unstructured":"Sase K, Tsukahara C, Fujita N, Arizono I, Otsubo M, Kitaoka Y (2023) Inhibition of p38 ameliorates axonal loss with modulation of autophagy in TNF-induced optic nerve damage. Int Ophthalmol 43:3067\u20133074. https:\/\/doi.org\/10.1007\/s10792-023-02706-1","journal-title":"Int Ophthalmol"},{"key":"3095_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/brain\/awm284","volume":"131","author":"P Lingor","year":"2008","unstructured":"Lingor P, T\u00f6nges L, Pieper N, Bermel C, Barski E, Planchamp V, B\u00e4hr M (2008) ROCK inhibition and CNTF interact on intrinsic signaling pathways and differentially regulate survival and regeneration in retinal ganglion cells. Brain 131:250\u2013263. https:\/\/doi.org\/10.1093\/brain\/awm284","journal-title":"Brain"},{"key":"3095_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.expneurol.2007.02.002","volume":"205","author":"H Sagawa","year":"2007","unstructured":"Sagawa H, Terasaki H, Nakamura M, Ichikawa M, Yata T, Tokita Y, Watanabe M (2007) A novel ROCK inhibitor, Y-39983, promotes regeneration of crushed axons of retinal ganglion cells into the optic nerve of adult cats. Exp Neurol 205:230\u2013240. https:\/\/doi.org\/10.1016\/j.expneurol.2007.02.002","journal-title":"Exp Neurol"},{"key":"3095_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.exer.2016.07.006","volume":"158","author":"PX Shaw","year":"2017","unstructured":"Shaw PX, Sang A, Wang Y, Ho D, Douglas C, Dia L, Goldberg JL (2017) Topical administration of a Rock\/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury. Exp Eye Res 158:33\u201342. https:\/\/doi.org\/10.1016\/j.exer.2016.07.006","journal-title":"Exp Eye Res"},{"issue":"1","key":"3095_CR19","doi-asserted-by":"publisher","first-page":"15709","DOI":"10.1038\/s41598-020-72748-3","volume":"10","author":"E Nishijima","year":"2020","unstructured":"Nishijima E, Namekata K, Kimura A, Guo X, Harada C, Noro T, Nakano T, Harada T (2020) Topical ripasudil stimulates neuroprotection and axon regeneration in adult mice following optic nerve injury. Sci Rep 10(1):15709. https:\/\/doi.org\/10.1038\/s41598-020-72748-3","journal-title":"Sci Rep"},{"issue":"8","key":"3095_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.298","volume":"4","author":"Y Fujita","year":"2013","unstructured":"Fujita Y, Sato A, Yamashita T (2013) Brimonidine promotes axon growth after optic nerve injury through Erk phosphorylation. Cell Death Dis 4(8):e763. https:\/\/doi.org\/10.1038\/cddis.2013.298","journal-title":"Cell Death Dis"},{"key":"3095_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101217","volume":"94","author":"Y Kitaoka","year":"2023","unstructured":"Kitaoka Y, Sase K (2023) Molecular aspects of optic nerve autophagy in glaucoma. Mol Aspects Med 94:101217. https:\/\/doi.org\/10.1016\/j.mam.2023.101217","journal-title":"Mol Aspects Med"},{"key":"3095_CR22","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1167\/iovs.13-13842","volume":"55","author":"K Yamamoto","year":"2014","unstructured":"Yamamoto K, Maruyama K, Himori N, Omodaka K, Yokoyama Y, Shiga Y, Morin R, Nakazawa T (2014) The novel Rho kinase (ROCK) inhibitor K-115: a new candidate drug for neuroprotective treatment in glaucoma. Invest Ophthalmol Vis Sci 55:7126\u20137136. https:\/\/doi.org\/10.1167\/iovs.13-13842","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3095_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainres.2007.04.013","volume":"18","author":"K Yamashita","year":"2007","unstructured":"Yamashita K, Kotani Y, Nakajima Y, Shimazawa M, Yoshimura S, Nakashima S, Iwama T, Haraet H (2007) Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons. Brain Res 18:215\u2013224. https:\/\/doi.org\/10.1016\/j.brainres.2007.04.013","journal-title":"Brain Res"},{"key":"3095_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1326-6-4","volume":"6","author":"WS Lambert","year":"2011","unstructured":"Lambert WS, Ruiz L, Crish SD, Wheeler LA, Calkins DJ (2011) Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons. Mol Neurodegener 6:4. https:\/\/doi.org\/10.1186\/1750-1326-6-4","journal-title":"Mol Neurodegener"},{"issue":"1","key":"3095_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12974-023-02818-6","volume":"20","author":"L Wang","year":"2023","unstructured":"Wang L, Liu T, Wang X, Tong L, Chen G, Zhou S, Zhang H, Liu H, Lu W, Wang G, Zhang S, Du D (2023) Microglia-derived TNF-\u03b1 contributes to RVLM neuronal mitochondrial dysfunction via blocking the AMPK-Sirt3 pathway in stress-induced hypertension. J Neuroinflammation 20(1):137. https:\/\/doi.org\/10.1186\/s12974-023-02818-6","journal-title":"J Neuroinflammation"},{"issue":"127","key":"3095_CR26","doi-asserted-by":"publisher","first-page":"111406","DOI":"10.1016\/j.intimp.2023.111406","volume":"25","author":"C Xu","year":"2024","unstructured":"Xu C, Tang Y, Yang H, Jiang S, Peng W, Xie R (2024) Harpagide inhibits the TNF-\u03b1-induced inflammatory response in rat articular chondrocytes by the glycolytic pathways for alleviating osteoarthritis. Int Immunopharmacol 25(127):111406. https:\/\/doi.org\/10.1016\/j.intimp.2023.111406","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"3095_CR27","doi-asserted-by":"publisher","first-page":"e110446","DOI":"10.13371\/journal.pone.0110446","volume":"9","author":"K Noda","year":"2014","unstructured":"Noda K, Nakajima S, Godo S, Saito H, Ikeda S, Shimizu T, Enkhjargal B, Fukumoto Y, Tsukita S, Yamada T, Katagiri H, Shimokawa H (2014) Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice. PLoS ONE 9(11):e110446. https:\/\/doi.org\/10.13371\/journal.pone.0110446","journal-title":"PLoS ONE"},{"key":"3095_CR28","doi-asserted-by":"publisher","first-page":"e22397","DOI":"10.1096\/fj.202101442RR","volume":"36","author":"WT Ho","year":"2022","unstructured":"Ho WT, Chang JS, Chen TC, Wang JK, Chang S, Yang M, Jou T, Wang I (2022) Inhibition of Rho-associated protein kinase activity enhances oxidative phosphorylation to support corneal endothelial cell migration. FASEB J 36:e22397. https:\/\/doi.org\/10.1096\/fj.202101442RR","journal-title":"FASEB J"},{"issue":"1","key":"3095_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.63.1.4","volume":"63","author":"Y Kitaoka","year":"2022","unstructured":"Kitaoka Y, Sase K, Tsukahara C, Fujita N, Arizono I, Kogo J, Tokuda N, Takagi H (2022) Axonal protection by netarsudil, a ROCK Inhibitor, is linked to an AMPK-autophagy pathway in TNF-induced optic nerve degeneration. Invest Ophthalmol Vis Sci 63(1):4. https:\/\/doi.org\/10.1167\/iovs.63.1.4","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3095_CR30","doi-asserted-by":"publisher","first-page":"e23343","DOI":"10.1096\/fj.202201872RR","volume":"38","author":"LR Timmins","year":"2024","unstructured":"Timmins LR, Ortiz-Silva M, Joshi B, Li YL, Dickson FH, Wong TH, Vandevoorde KR, Nabi IR (2024) Caveolin-1 promotes mitochondrial health and limits mitochondrial ROS through ROCK\/AMPK regulation of basal mitophagic flux. FASEB J 38:e23343. https:\/\/doi.org\/10.1096\/fj.202201872RR","journal-title":"FASEB J"},{"issue":"649","key":"3095_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbrc.2023.01.088","volume":"15","author":"Y Nagai","year":"2023","unstructured":"Nagai Y, Matoba K, Yako H, Ohashi S, Sekiguchi K, Mitsuyoshi E, Sango K, Kawanami D, Utsunomiya K, Nishimura R (2023) Rho-kinase inhibitor restores glomerular fatty acid metabolism in diabetic kidney disease. Biochem Biophys Res Commun 15(649):32\u201338. https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.088","journal-title":"Biochem Biophys Res Commun"},{"key":"3095_CR32","doi-asserted-by":"publisher","first-page":"e12675","DOI":"10.1111\/micc.12675","volume":"28","author":"Q Shao","year":"2021","unstructured":"Shao Q, Xia J, Wu P, Ying J (2021) Dexmedetomidine protects cardiac microvascular endothelial cells from the damage of ogd\/r through regulation of the ppar\u03b4-mediated autophagy. Microcirculation 28:e12675. https:\/\/doi.org\/10.1111\/micc.12675","journal-title":"Microcirculation"},{"key":"3095_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12017-023-08745-2","volume":"25","author":"P Chen","year":"2023","unstructured":"Chen P, Chen X, Zhang H, Chen J, Lin M, Qian H, Gao F, Chen Y, Gong C, Zheng X, Zheng T (2023) Dexmedetomidine regulates autophagy via the AMPK\/mTOR pathway to improve SH-SY5Y-APP cell damage induced by high glucose. Neuromolecular Med 25:415\u2013425. https:\/\/doi.org\/10.1007\/s12017-023-08745-2","journal-title":"Neuromolecular Med"},{"key":"3095_CR34","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s12035-016-9824-3","volume":"54","author":"VG Yerra","year":"2017","unstructured":"Yerra VG, Areti A, Kumar A (2017) Adenosine monophosphate-activated protein kinase abates hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation. Mol Neurobiol 54:2301\u20132312. https:\/\/doi.org\/10.1007\/s12035-016-9824-3","journal-title":"Mol Neurobiol"},{"key":"3095_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12929-023-00978-4","volume":"30","author":"AYT Wu","year":"2023","unstructured":"Wu AYT, Sekar P, Huang DY, Hsu SH, Chan CM, Lin WW (2023) Spatiotemporal roles of AMPK in PARP-1- and autophagy-dependent retinal pigment epithelial cell death caused by UVA. J Biomed sci 30:91. https:\/\/doi.org\/10.1186\/s12929-023-00978-4","journal-title":"J Biomed sci"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03095-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03095-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03095-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:38:16Z","timestamp":1741880296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03095-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3095"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03095-9","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"assertion":[{"value":"12 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by the Ethics Committee of the Institute of Experimental Animals of St. Marianna University School of Medicine (Approval No. 2308009).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}],"article-number":"173"}}